Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
9.64
+0.22 (2.34%)
At close: Mar 6, 2026
SHE:300009 Market Cap
SHE:300009 has a market cap or net worth of 16.07 billion as of March 6, 2026. Its market cap has increased by 12.27% in one year.
Market Cap
16.07B
Enterprise Value
14.97B
Revenue
2.58B
Ranking
n/a
PE Ratio
24.00
Stock Price
9.64
Market Cap Chart
Since October 30, 2009, SHE:300009's market cap has increased from 4.21B to 16.07B, an increase of 282.04%. That is a compound annual growth rate of 8.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 16.07B | 0.66% |
| Dec 31, 2025 | 15.97B | 10.76% |
| Dec 31, 2024 | 14.41B | -15.68% |
| Dec 29, 2023 | 17.09B | 9.42% |
| Dec 30, 2022 | 15.62B | -27.16% |
| Dec 31, 2021 | 21.45B | 7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 20.05B |
| BrightGene Bio-Medical Technology | 17.37B |
| Sinocelltech Group | 16.43B |
| Jinyu Bio-technology | 16.25B |
| Inner Mongolia Furui Medical Science | 14.76B |
| Tibet Cheezheng Tibetan Medicine | 14.51B |
| Pacific Shuanglin Bio-pharmacy | 13.16B |
| Vcanbio Cell & Gene Engineering Corp., | 12.67B |